Next Article in Journal
Anti-Cancer Activity of Porphyran and Carrageenan from Red Seaweeds
Next Article in Special Issue
Novel Synthetic Approaches for Bisnaphthalimidopropyl (BNIP) Derivatives as Potential Anti-Parasitic Agents for the Treatment of Leishmaniasis
Previous Article in Journal
Co-Adsorption of H2O, OH, and Cl on Aluminum and Intermetallic Surfaces and Its Effects on the Work Function Studied by DFT Calculations
Previous Article in Special Issue
Antibacterial and Antifungal Activity of Three Monosaccharide Monomyristate Derivatives
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 24
Issue 23
10.3390/molecules24234285
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis of Amino Acid–Naphthoquinones and In Vitro Studies on Cervical and Breast Cell Lines

by
Ernesto Rivera-Ávalos
1,
Denisse de Loera
1,
Jorge Gustavo Araujo-Huitrado
2,
Ismailia Leilani Escalante-García
3,
Miguel Antonio Muñoz-Sánchez
3,
Hiram Hernández
3,
Jesús Adrián López
2,* and
Lluvia López
4,*
1
School of Chemistry, Universidad Autónoma de San Luis Potosí, Av. Manuel Nava No. 6, SLP 78210, Mexico
2
Laboratorio de microRNAs y Cáncer, Unidad Académica de Ciencias Biológicas, Universidad Autónoma de Zacatecas, Av. Preparatoria No.301, ZAC 98068, Mexico
3
Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Carr. Zacatecas–Guadalajara km 6, ZAC 98160, Mexico
4
Instituto de Investigación de Zonas Desérticas, Universidad Autónoma de San Luis Potosí, Altaír No. 200, SLP 78377, Mexico
*
Authors to whom correspondence should be addressed.
Molecules 2019, 24(23), 4285; https://0-doi-org.brum.beds.ac.uk/10.3390/molecules24234285
Submission received: 16 October 2019 / Revised: 15 November 2019 / Accepted: 18 November 2019 / Published: 25 November 2019
(This article belongs to the Special Issue Application of Organic Synthesis to Bioactive Compounds)
Browse Figures
Review Reports Versions Notes

Abstract

:
We performed an extensive analysis about the reaction conditions of the 1,4-Michael addition of amino acids to 1,4-naphthoquinone and substitution to 2,3-dichloronaphthoquinone, and a complete evaluation of stoichiometry, use of different bases, and the pH influence was performed. We were able to show that microwave-assisted synthesis is the best method for the synthesis of naphthoquinone–amino acid and chloride–naphthoquinone–amino acid derivatives with 79–91% and 78–91% yields, respectively. The cyclic voltammetry profiles showed that both series of naphthoquinone–amino acid derivatives mainly display one quasi-reversible redox reaction process. Interestingly, it was shown that naphthoquinone derivatives possess a selective antitumorigenic activity against cervix cancer cell lines and chloride–naphthoquinone–amino acid derivatives against breast cancer cell lines. Furthermore, the newly synthetized compounds with asparagine–naphthoquinones (3e and 4e) inhibited ~85% of SiHa cell proliferation. These results show promising compounds for specific cervical and breast cancer treatment.

1. Introduction

Naphthoquinone (NQ) is a nucleus found in several natural and synthetic compounds that offers several applications, such as pigments, and many biological properties, including antibacterial, antifungal, anticancer, antimalarial, and antiviral, among others [1,2]. Regarding cytotoxic activity, several studies have reported that naphthoquinones with different substituents like paclitaxel, esters, metals, furans, carbazoles, or inclusive with carbohydrates in their structure, among others, present effects of diminishing cell proliferation [3,4,5].
These properties are principally attributed to the oxidant-reductive characteristics of the naphthoquinones, which allow the generation of dianions or semiquinone radicals. In the last decades, some publications have been dedicated to finding an explanation for the formation of these intermediates in the synthetic mechanism, and their properties that have produced different compounds with a plethora of applications of biological importance and effects that involve intra- or intermolecular interactions. One of the principal effects of these compounds is the generation of reactive oxygen species (ROS), producing cytotoxicity in different cell lines [6,7,8,9,10,11,12,13]. ROS generation with naphthoquinones represents a challenge in the design of new active compounds, principally with anticancer effect. In this context, the addition/substitution on naphthoquinone moiety by atoms or groups such as flour, oxygen, or amine can be modulated by redox properties, decreasing the toxicity levels and maintaining or potentiating the biological effect [14,15,16]. Several quinones from natural origin, like β-laphachone and menadione, among others, have been well characterized by their specific selectivity for cell lines, responding to temporal curse and dose response. Cell proliferation inhibition could be achieved by the induction of apoptosis, topoisomerase II-α inhibition, and ROS generation, among others [4]. Furthermore, it has been shown that β-lapachone inhibits epidermal growth factor (pEGFR), protein kinase B (pAKT/PKB), glycogen synthase kinase (pGsk-3β), cyclin D1, and cyclooxygenase-2 (COX-2) protein expression in a dose-dependent manner [17]. Interestingly, the naphthoquinone NSC 95,397 is used as a general potent inhibitor of cell cycle division 25C (Cdc25) [18]. Naphthoquinone regulation depends of the composition of its substituents, as well as targets and cellular components that could be inhibited and/or activated. Several naphthoquinones have been produced; however, they present non-desirable effects in cancer therapy use. Therefore, new compounds produced by alternative methods are imperative for cancer treatment.
In this regard, the synthesis and biological activities of some naphthoquinone–amino acids have been reported in several publications; nonetheless, all of these methodologies present different drawbacks, like low yields and/or long reaction times [19,20,21,22,23,24,25,26,27,28,29]. To our knowledge, the synthesis of naphthoquinone–amino acid derivatives has not been reported using microwave and ultrasound irradiation, which offer diverse advantages to conventional synthesis. In previous works, our group reported the synthesis of some Juglone and Lawsone derivatives using ultrasound and microwave irradiation under mild reaction conditions [30,31,32].
In this paper, we present the synthesis of a series of 1,4-naphthoquinone–amino acid (3a–e) and 2,3-dichloronaphhtoquinone (4a–4e) derivatives under several activation methods, such as room temperature synthesis (RTS), reflux synthesis (RS), microwave-assisted synthesis (MAS), and ultrasound-assisted synthesis (UAS), and determined the effectivity on the system. Newly synthesized compounds are promising in the cancer field. In the present work, we were able to incorporate alanine, phenylalanine, methionine, glycine, and asparagine to both naphthoquinones (1a,b) by MAS and evaluated their effect in the cervical cancer cell line, SiHa, and the breast cancer cell line, MCF-7. The incorporation of amino acids to naphthoquinones could enhance their cytotoxicity capacity, as well as their specificity.

2. Results

2.1. Chemistry

In a general method to prepare 3a–e derivatives, the corresponding amino acid 2a–c was added in a 1,4-type bond form to the naphthoquinone 1a, using initially, the conditions reported in the literature (Figure 1) [19,23]. These conditions are shown as room temperature synthesis (RTS) and reflux synthesis (RS) in Table 1. Base effect was studied using potassium carbonate (K2CO3) and trimethylamine (TEA) in equimolar proportion. However, RTS and RS methodologies showed trace or no production of the desired compounds when no base was used. Only for RS and base addition were the yields increased to a range of 20–50%. A modified methodology was performed with microwave (MAS) irradiation to determine the effect on the system. Interestingly, when the system was subjected to microwave radiation, the yield of the derivatives was in the range of 28–30% without base. Furthermore, the compound yields were increased when a base was used. The results indicate that TEA and potassium hydroxide (KOH) were better bases, among others, to produce the derivative compounds (Table 1). It was determined that the optimum pH for greater product formation was 9–10. At a lower pH, the reactions became very slow, and under higher pH, the presence of secondary products was observed, as when the K2CO3 was used in an equimolar concentration (1 mmol) and not in solution.
With these established conditions, we performed the synthesis of compounds 3a–e and 4a–e with different bases and stoichiometric proportions between NQ and amino acids under MAS and ultrasound (UAS) as an alternative method (Table 2). It was determined that the best yields were obtained with KOH and TEA solutions. On the other hand, the yields were dependent of the proportion of each amino acid in the solution; besides, reaction times were reduced significantly to 25 min under MAS. In most cases, lower yields were obtained under UAS in comparison with MAS. Remarkably, the yield was dependent on pH, stoichiometry, and base used for each amino acid incorporation (Table 2).
In several investigations, the generation of compounds 3a, 3b, 3d, 4a, and 4d has been reported [19,20,21,22,23,24,25,26,27,28,29], and their boiling point, infrared, and 1H NMR spectra have been determined. Compounds 4b, 4c have been reported and used as intermediates for secondary reactions or biological evaluations, but we did not find their complete characterization [33,34], while 3c, 3e, and 4e have not been previously reported and, therefore, their complete characterization was carried out.

2.2. Electrochemical Studies by Cyclic Voltammetry

The electrochemical reduction behavior of 1,4-naphthoquinone–amino acid (3a–e) and 2,3-dichloro-1,4-naphhtoquinone derivatives (4a–e) was investigated by cyclic voltammetry (CV) in TBABF4 0.1M/DMSO as supporting electrolyte at a scan rate of 100 mV·s−1. Figure 2A,B shows the cyclic voltammograms curves of compounds 3a–e and 4a–e, respectively.
In Figure 2A,B, the CV profiles of the naphthoquinone derivative compounds mainly display one quasi-reversible redox reaction process as compared to the two reduction peaks of typical quinone derivatives in aprotic media [35,36]. Interestingly, compound 3a (Figure 2A) does not show any significant electroactive processes in the studied potential range. The irreversible reduction peak observed near to −0.8 V for 3b–e and −0.9 V for 4a–e in Figure 2A,B, respectively, are related to the oxidation reactions occurring by electron dislocations of the quinone derivatives at more positive potentials, >−0.7 V or >−0.5 V for both 1,4-naphthoquinone and 2,3-dichloro-1,4-naphtoquinone–amino acid derivatives, respectively. Additionally, the irreversible reduction–oxidation peaks were not observed when further cyclic voltammetry studies were performed at different scan rates in the cathodic potential region for the evaluation of the redox reactions.
The main electrochemical parameters of the redox reaction of each naphthoquinone derivative are reported in Table 3. Overall, the half-wave potentials (E1/2) for the redox reaction peak were near −1.24 V for 3b–e and −1.12 V for 4a–e, respectively (Table 3). The redox reaction is a diffusion-controlled process, since the cathodic peak current density (ipc) or the anodic peak current density (ipa) are proportional to the square root of the scan rate (ipc vs. v1/2) [37,38].
In addition to this, the ratio of the cathodic peak current (ipc) to the anodic peak current (ipa) is close to one for the naphthoquinone–amino acid derivatives 3b–e and 4a–e, as described for reversible systems (Table 3). However, the potential values of cathodic peak (Epc) to anodic peak (Epa) separation (ΔEp) are quite large and disagree with the theoretical value reported for a one-electron reversible system, ΔEp > 60 mV, as shown in Table 3 [37]. Thus, the redox reaction process is considered quasi-reversible. Furthermore, it is unclear if the reduction reaction of the quinone moiety occurs via a single-step two-electron process as compared to the two successive one-electron transfer steps producing semiquinone (Q−) and quinone dianion (Q2−), as typically observed for well-behaved quinone derivatives (Q) in nonaqueous media [35,39,40,41,42,43].

2.3. Effect of Naphthoquinone–Amino Acid Derivatives in Cell Proliferation of Cervical Cancer Cell Line SiHa and Breast Cancer Cell Line MCF-7

SiHa cells were treated with 0.75 mM of naphthoquinone–amino acid derivatives 3a–e and 4a–e; however, the concentration was extremely toxic for the cell line (data not shown). Therefore, 0.1 mM was used to register the proliferation effect on SiHa and MCF-7 cells. Compounds with glycine (3a) and asparagine (3e) substituents showed the most potent effect, inhibiting ~80% of proliferation in SiHa cells, while in MCF-7, glycine (3a), chloride glycine (4a), and chloride asparagine (4e) showed a proliferation inhibition near 90% (Figure 3A,B). Interestingly, the chloride substituent did not modify the effect in SiHa cells, suggesting an effect directly mediated by the amino acids glycine and asparagine (compare 3a and 3e versus 4a and 4e, Figure 3A), while in MCF-7, this substituent increased the effect of naphthoquinone–amino acid compounds (compare 3a, 3b, and 3c versus 4a, 4b, and 4c). In contrast, 4b increased 10% of inhibition compared with 3b (4b = 72.5% versus 3b = 61.3%; Figure 3A). However, chloride incorporation did not always diminish proliferation, as it could be observed in 3c versus 4c presenting 62.6% and 54.8% of proliferation inhibition in SiHa cells, respectively (Figure 3A). Remarkably, in MCF-7 cells, chloride addition increased the proliferation inhibition effect of the compounds (Figure 3B), suggesting a specific and particular effect for breast cell line. The 3d compound with amino acid phenylalanine showed a bigger proliferation inhibition in MCF-7 cells (57%) over SiHa cells (40%). Interestingly, for the chlorine compound 4d, a similar effect was observed for both cell lines, presenting 69.8% of proliferation inhibition (Figure 3A,B).

3. Discussion

The naphthoquinone–amino acid derivatives have been previously reported; nonetheless, in this investigation, we performed a very extensive analysis about the reactivity of the equivalents of each amino acid used in the reactions. The results show a direct dependence of the pH on derivative production since, under pH = 9, reactions became very slow and above pH = 10.5, several secondary reactions appeared and reduced the yield, generating some different compounds that make difficult the purification. We optimized reactions under ultrasonic and microwave irradiation, particularly in the latter one, showing the highest efficiency obtaining the best yields 79–91% (3a–e) and 78–91% (4a–e) compared with the literature reported data, and significantly reducing the reaction times from days or hours to only a few minutes under the optimized conditions.
A full description of the electron-transfer mechanism of the naphthoquinones with amino acid substituents is beyond the scope of the present paper. However, it is assumed that the quinone dianion is possibly stabilized by an intramolecular hydrogen bond, since the dissociation of proton donor groups, i.e., carboxyl group, in DMSO is not facile, thus, cannot protonate the dianion [44,45,46,47]. In such a case, the second redox process merges with the first (Figure 2), owing to the stabilization of the dianion by a hydrogen bond, as reported elsewhere [35,46,48,49]. For instance, the E1/2 values computed for compounds 3b–e (~1.24 V) are located at the mid-point of the half-wave potential values determined for the semiquinone (Q−) and the dianion (Q2−) redox reaction peaks of the parental 1,4-naphtoquinone compound studied at same experimental conditions, −0.9 V or −1.6 V, respectively (data not shown). Likewise, the redox reaction process peak of the naphthoquinone–amino acid and chloride derivatives (4a–e) is positioned at E1/2 ~ −1.12 V, as shown in Table 3, while the E1/2 values for the Q− and Q2– redox reaction steps of the 2,3-dichloro-1,4 naphthoquinone compound are −0.65 V and −1.37 V, respectively (data not show).
Particularly, naphthoquinone derivatives with glycine and chloride substituents (4a) present a noticeable electrochemical improvement regarding naphthoquinones with glycine (3a) (Figure 2). These results are associated to the electron-accepting capacity of the chloride substituent, and possibly to some conformational effects which modify the electronic configuration of the naphthoquinone–amino acid derivatives, facilitating the reduction processes [41,50]. It is then expected that naphthoquinone compounds with amino acids and chloride substituents (4a–e) present higher biological activity than derivatives (3a–e), as estimated by their E1/2 values, since reactive oxygen species (ROS) generation is facilitated at compounds with more positive E1/2 [39,40,41,42,49,51]. However, additional factors such as solvents, nature of supporting electrolyte, protonation–deprotonation equilibrium, and intra- and intermolecular hydrogen bonding also play important roles in determining the half-wave potential of the redox reaction processes, probably affecting cellular biological processes.
Recently, a proliferation inhibition effect of naphthoquinone–amino acid derivatives in different cell lines was described. In the ileocecal adenocarcinoma cell line HCT-8, it was shown an 86, 84, and 59% of proliferation inhibition with phenylalanine, alanine, and proline naphthoquinone derivatives. In the breast cancer cell line MDAMB-435, it was shown a 100, 100, and 36%, while in human multiforme cell line SF-295 86, 83, and 59% of proliferation inhibition, respectively [23]. Glycine incorporation in naphthoquinone structure is used to add methyl groups that would extend the molecules to resemble other amino acids presenting different activities [17]. Naphthoquinones with amino acids could probably interact with proteins and/or complexes, inhibiting several molecular processes like replication, transcription, and translation. Moraes et al. [23] added three complete amino acids to naphthoquinone structure, showing similar cytotoxicity to doxorubicin. The effect of glycine, alanine, and phenylalanine derivatives synthesized by Moraes et al. was similar to our results. Marastoni et al. [18] incorporated leucine, asparagine, phenylalanine, and serine into naphthoquinone with diamine alkyl spacers, inhibiting three subunits of proteasome linked to proliferation inhibition of the breast cancer cell line MDA and ovarian cancer cell line A2780 in the range of 100 μM, similar as in the present study. However, in our study, we used a number of 1 × 105 cells, while they used 15 × 103 cells; therefore, the molecules per cell that we used in our study was less than Marastoni et al.’s study.
The newly synthetized compounds with asparagine–naphthoquinones inhibited ~85% of SiHa cell proliferation. Inhibition grade of naphthoquinone–amino acid derivatives 3a, 3e, 3b, 3c, and 3d ranked from 85 to 40% in SiHa cells. In contrast, MCF-7 cells presented an effect ranking from 90 to 30% of proliferation inhibition. In order from higher to lower, the compounds 4a, 4e, 4c, and 4d and 4b showed their effect. It could be theorized that the differential effects observed may be dependent on hydropathy index and protein occurrence of the compounds. Glycine and asparagine present the negative hydropathy index −0.4 and −4.5, respectively. Nevertheless, it should be noted that asparagine’s hydropathy index is more negative that glycine’s hydropathy index, even though it is more abundant in proteins than asparagine—7.2 and 5.1, respectively. This hypothesis needs several experimental studies to be addressed. However, glycine– and asparagine–naphthoquinones, as well as dichloride compounds, show selectively antitumorigenic properties in cervix and breast cancer cell lines, respectively, positioning them as promising compounds for specific cancer treatment.

4. Materials and Methods

4.1. General

Commercially supplied 1,4-naphthoquinone, 2,3-dichloronaphthoquinone, alanine, glycine, methionine, phenylalanine, and asparagine were used for the synthesis without further purification. 1H and 13C nucleus magnetic resonance (NMR) spectra were recorded on a Bruker Fourier 300 MHz spectrometer (1H at 300, 13C at 75 MHz, Silberstreifen, Rheinstetten, Germany) and Bruker Avance III 400 MHz spectrometer (1H at 400, 13C at 101 MHz, Silberstreifen, Rheinstetten, Germany). The spectra were acquired from solution in dimethylsulfoxide-d6 and methanol-d4 at room temperature, TMS as internal reference, the chemical shifts (δ) are expressed in part per million (ppm) and the coupling constants (J) in Hz. High-resolution mass spectra (HRMS) were measured with a Jeol JMS-AccuTOF through DART (Direct Analysis in Real Time, Peabody, MA, USA) and by ESI (electrospray ionization) in an Agilent 6200 Series TOF (Santa Clara, CA, USA) and 6500 Series Q-TOF LC/MS System (Santa Clara, CA, USA). Infrared spectra were recorded on a Thermo Scientific NICOLET iS10 with ATR dispositive (SMART iTR, Madison, WI, USA). Melting points were determined using a Bicote-Stuart SMO 10 apparatus (Stone, Staffordshire, UK) and were uncorrected. Microwave-assisted synthesis (MAS) was performed on a CEM Mars 6 oven with a carrousel device (Matthews, NC, USA). Ultrasound-assisted synthesis (UAS) was carried out in an Autoscience Ultrasonic cleaner-AS2060B with 60 Watts of power (Lewisville, TX, USA). TLC was performed using silica gel 60 PF254 containing gypsum (Merck, Darmstadt, Germany). The isolated reaction products were found to be >95% purity by NMR analysis (See Supplementary Materials).

4.2. General Procedure for the Optimization of the Reaction Conditions for the Synthesis of Compounds 3a–c

A solution of the appropriate amino acid 2a–c (1 mmol) in 40 mL of EtOH/H2O (4:1) was basified with several bases (pH = 9–10), and then a solution of 1 mmol of 1,4-naphthoquinone (1a) in ethanol (10 mL) was added. The mixture was activated by different methods, such as room temperature (RTS), reflux (RS), and microwave irradiation (MAS). Solvent and base effect were studied in the reaction yields, using K2CO3 (3 N) and triethylamine (TEA) (Figure 1). The progress reaction was monitored by TLC, using MeOH/CHCl3 (9:1) as eluent mixture. Finally, 20 mL of HCl (1 N) was added and the precipitated product was filtered and purified by flash column chromatography, starting with dichloromethane (DCM) and changing the polarity to finish with methanol.

4.3. Optimization of the Reaction Conditions for the Synthesis of Compounds 3a–c Under Microwave Irradiation

In 15 mL of dioxane/H2O (4:1) or 30 mL of EtOH/H2O (4:1), 1.5 to 2 mmol of respective amino acid was added, the mixture was basified with several bases (TEA, K2CO3 aq., AcONa, or KOH aq.) to obtain a pH of 9–10, and activated under microwave irradiation with the following parameters: 110 °C, 250 W for a time of 10 min. Then, a solution of naphthoquinone (1a) in 5 mL or 20 mL of the respective mixture was added; the reaction solution was irradiated with the same parameters by 30 min. After the time of reaction, 20 mL of HCl (1 N) was added, and the compounds were purified with the methodology previously descripted.

4.4. Optimized Reaction Conditions Under Microwave Irradiation for the Synthesis of Compounds 3a–e and 4a–e

A solution of respective amino acid (1.5–2.0 mmol) in dioxane/H2O (4:1, 15 mL for 3a–e derivatives or 20 mL for 4a–e derivatives) was basified with TEA or KOH aq. (pH 9–10) and activated under microwave irradiation (110 °C, 250 W for a time of 10 min). Then, a solution of naphthoquinone 5 mL (1a) or 2,3-dichloro-1,4-naphthoquinone (1b) 10 mL of dioxane/water mixture was added; the reaction mixture was irradiated with the same parameters by 20 min. After the time of reaction, 20 mL of HCl (1N) was added, and the compounds were purified with the methodology previously descripted. Under this methodology, compounds 3a, 3d and 3e, 4b, 4c, and 4e were purified as was previously described, while 3b, 3c, 4a, and 4d were obtained by filtration without further purification.

4.5. General Procedure for the Synthesis of Compounds 3a–e and 4a–6 Under Ultrasonic Irradiation

For 3a–e derivatives, 15 mL of dioxane/H2O (4:1) was used, and 20 mL for 4a–e compounds. Then, 1.5–2.0 mmol of respective amino acid in solution dioxane/H2O was basified with TEA or KOH aq. to pH 9–10, and activated by ultrasound at 25 °C and 15 min. Then, 5 mL a solution of naphthoquinone (1a) or 10 mL of 2,3-dichloro-1,4-naphthoquinone (same proportion dioxane/H2O) was added; the reaction mixture was irradiated again for 45 min (maximum temperature of 40 °C). After the time of reaction, 20 mL of HCl (1 N) was added, and the products were purified by column chromatography with the previously described methodology.

4.6. Spectroscopic Characterization of Amino Acid–1,4-naphthoquinone Derivatives

2-((1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)acetic acid (3a). Red-brown powder. Yield: 86%. m. p.: 166–168 °C; IR (ATR): 3366, 1721, 1681, 1600, 1555, 1505, 1299, 1123 cm−1; 1H NMR (300 MHz, DMSO-d6) δ: 12.96 (s, 1H), 7.99 (dd, J = 7.6/0.9 Hz, 1H), 7.93 (dd, J = 7.6/0.9 Hz, 1H), 7.83 (td, J = 7.5/1.4 Hz, 1H), 7.74 (td, J = 7.5/1.4 Hz, 1H), 7.46 (t, J = 6.2 Hz, 1H, NH), 5.63 (s, 1H), 3.99 (d, J = 6.2 Hz, 2H) ppm. (Characterization according to literature [23].)
2-((1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino) propanoic acid (3b). Yellow powder. Yield: 91%. m. p.: 145–147 °C; IR (ATR): 3357, 1725, 1685, 1604, 1550, 1492, 1366, 1310, 1298 cm−1; 1H NMR (300 MHz, DMSO-d6) δ: 13.08 (s, 1H), 8.00 (d, J = 7.5 Hz, 1H), 7.93 (d, J = 7.5 Hz, 1H), 7.84 (t, J = 7.5 Hz, 1H), 7.74 (t, J = 7.5 Hz, 1H), 7.27 (d, J = 7.6 Hz, 1H, NH), 5.66 (s, 1H), 4.21 (q, J = 7.3 Hz, 1H), 1.45 (d, J = 7.0 Hz, 3H) ppm. (Characterization according to literature [23].)
2-((1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)-4-(methylthio)butanoic acid (3c). Orange powder. Yield: 87%. m. p.: 146–148 °C; IR (ATR): 3339, 1716, 1676, 1600, 1550 1505 1447, 1334, 1307, 1222 cm−1; 1H NMR (DMSO-d6) δ: 13.19 (s, 1H), 8.00 (td, J = 7.3/1.2 Hz, 1H), 7.94 (td, J = 7.4/1.2 Hz, 1H), 7.84 (td, J = 7.5/1.4 Hz, 1H), 7.75 (td, J = 7.5/1.5 Hz, 1H), 7.40 (d, J = 8.3 Hz, 1H, NH), 5.70 (s, 1H), 4.27 (td, J = 8.1/5.1 Hz, 1H), 2.64–2.41 (m, 2H), 2.28–2.08 (m, 2H), 2.05 (s, 3H) ppm; 13C NMR (DMSO-d6) δ: 182.3, 181.7, 172.7, 148.5, 135.4, 133.2, 132.9, 130.8, 126.5, 125.8, 101.3, 54.1, 30.4, 30.1, 15.0 ppm; HRMS (DART/Q-TOF) m/z: [M + H]+ for C15H16NO4S: 306.0755; Found: 306.0801.
2-((1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)-3-phenylpropanoic acid (3d). Red powder. Yield: 85%. m. p.: 215–217 °C; IR (ATR): 3348, 1680, 1604, 1564, 1496, 1334, 1249, 1119 cm−1; 1H NMR (300 MHz, DMSO-d6) δ: 7.93 (d, J = 8.0 Hz, 1H), 7.91 (d, J = 8.6 Hz, 1H), 7.80 (t, J = 7.4 Hz, 1H), 7.69 (t, J = 7.4 Hz, 1H), 7.28 (d, J = 4.2 Hz, 1H, NH), 7.15 (m, 4H), 7.11 (s, 1H), 5.57 (s, 1H), 4.01 (q, J = 5.2 Hz, 1H), 3.14 (m, J = 7.2 Hz, 2H) ppm. (Characterization according to literature [23].)
4-amino-2-((1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)-4-oxobutanoic acid (3e). Dark-red powder. Yield 79%. M. p.: 147–149 °C; IR (ATR): 3438, 1734, 1682, 1591, 1528, 1379, 1276, 1231 cm−1; NMR 1H (300 MHz, DMSO-d6) δ: 7.96 (d, J = 7.9 Hz, 1H), 7.91 (d, J = 7.5 Hz, 1H), 7.81 (t, J = 7.0 Hz, 1H), 7.75 (s, 2H, NH), 7.69 (t, J = 7.2 Hz, 1H), 7.37 (d, J = 7.0 Hz, 1H, NH), 6.91 (s, 1H, NH), 5.67 (s, 1H), 3.93 (q, J = 6.3/5.8 Hz, 1H), 2.64–2.41 (m, 1H) ppm; 13C NMR (DMSO-d6) δ: 181.7, 181.4, 172.8, 172.7, 146.9, 134.9, 133.3, 132.2, 130.3, 125.9, 125.4, 99.8, 53.6, 38.3 ppm; HRMS (ESI/Q-TOF) m/z: [M + Na]+ for C14H12N2O5Na: 311.0644; Found: 311.0675.

4.7. Spectroscopic Characterization of Amino Acid–2,3-dichloronaphthoquinone Derivatives

2-((3-chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)acetic acid (4a). Orange powder. Yield: 91%. M. p.: 168–170 °C; IR (ATR): 3339, 1718, 1671 1591, 1564, 1420, 1249, 1105, 714 cm−1; 1H NMR (300 MHz, DMSO-d6) δ: 12.95 (s, 1H), 7.98 (dd, J = 7.4/1.4 Hz, 2H), 7.84 (td, J = 7.5/1.4 Hz, 1H), 7.75 (td, J = 7.5/1.4 Hz, 1H), 7.53 (t, J = 6.3 Hz, 1H, NH), 4.39 (d, J = 6.6 Hz, 2H) ppm. (Characterization according to literature [24].)
2-((3-chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)propanoic acid (4b). Orange–red powder. Yield: 95%. m. p.: 227–229 °C; IR (ATR): 3339, 1716, 1676, 1600, 1550 1505 1447, 1334, 1307, 1222 cm−1; 1H NMR (400 MHz, Methanol-d4) δ: 7.96 (dd, J = 7.5/3.8 Hz, 2H), 7.72 (td, J = 7.5/1.3 Hz, 1H), 7.63 (td, J = 7.6/1.2 Hz, 1H), 7.21 (d, J = 8.3 Hz, 1H), 4.96 (q, J = 6.8 Hz, 1H), 1.54 (d, J = 6.8 Hz, 3H) ppm; 13C NMR (101 MHz, Methanol-d4) δ: 186.5, 179.8, 176.7, 149.5, 134.5, 132.3, 131.4, 129.9, 126.4, 125.9, 121.1, 53.4, 20.4 ppm; HRMS (DART/Q-TOF) m/z: [M + H]+ for C13H10ClNO4: 280.0332; Found: 280.0387.
2-((3-chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)-4-(methylthio)butanoic acid (4c). Orange powder. Yield: 89%. m. p.: 185–188 °C; IR (ATR): 3276, 1710, 1676, 1586, 1546, 1375, 1137, 1006, 723 cm−1; 1H NMR (400 MHz, DMSO-d6) δ 8.23 (d, J = 7.3 Hz, 2H), 8.09 (t, J = 7.4 Hz, 1H), 8.01 (t, J = 7.5 Hz, 1H), 7.10 (d, J = 8.1 Hz, 1H, NH), 5.06 (q, J = 5.9 Hz, 1H), 2.87–2.70 (m, 2H), 2.49–2.40 (m, 1H), 2.27 (s, 3H), 1.51–1.46 (m, 1H) ppm; 13C NMR (101 MHz, DMSO-d6) δ 179.9, 175.4, 173.1, 143.8, 135.1, 132.7, 132.11, 129.8, 126.6, 125.9, 119.7, 56.4, 33.8, 28.9, 14.8 ppm. HRMS (DART/Q-TOF) m/z: [M + H]+ for C15H14ClNO4S: 340.0366; Found: 340.0401.
2-((3-chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)-3-phenylpropanoic acid (4d). Orange–red powder. Yield: 91%. m. p.: 175–177 °C; IR (ATR): 3303, 1743, 1676, 1600, 1555, 1406, 1294, 1262, 1226, 700 cm−1; 1H NMR (300 MHz, DMSO-d6) δ: 7.94 (dd, J = 9.0/2.9 Hz, 2H), 7.81 (td, J = 7.5/1.5 Hz, 1H), 7.73 (td, J = 7.5/1.5 Hz, 1H), 7.29–7.15 (m, 5H), 6.68 (d, J = 4.3 Hz, 1H), 5.32 (q, J = 6.2 Hz, 1H), 3.25 (dd, J = 5.7/2.8 Hz, 2H) ppm. (Characterization according to literature [22,29].)
4-amino-2-((3-chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)-4-oxobutanoic acid (4e). Red powder. Yield: 85%. m. p.: 207 °C; IR (ATR): 3442, 3280, 3195, 1671, 1626, 1595, 1559 1393, 1298, 1276, 719 cm−1; 1H NMR (300 MHz, DMSO-d6) δ: 7.94 (dd, J = 7.9/4.5 H, 2H), 7.81 (t, J = 6.1 Hz, 1H), 7.72 (t, J = 7.4 Hz, 1H), 7.54 (d, J = 3.7 Hz, 1H), 7.04 (s, 1H), 5.00–4.81 (m, 1H), 2.70–2.54 (m, 2H).; 13C NMR (DMSO-d6) δ: 181.7, 181.4, 172.8, 172.7, 146.9, 134.9, 133.3, 132.2, 130.3, 125.9, 125.4, 99.8, 53.6, 38.3 ppm; HRMS (ESI/Q-TOF) m/z: [M + Na]+ for C14H11ClN2O5Na: 345.0254; Found: 345.0287.

4.8. Cyclic Voltammetry

Cyclic voltammetry (CV) was performed in a conventional three-electrode electrochemical cell using a potentiostat/galvanostat (EG&G, PAR VersaStat 3). A polished glassy carbon disk electrode (GC) (0.07 cm2, BASi USA) was employed as working electrode. Prior to each experiment, the GC electrode was polished to mirror finishing with 0.3 mm and 0.05 mm alumina and washed with distilled water, and sonicated in ethanol for 5 min. The counter electrode was a Pt wire (Alfa-Aesar, USA), and a home-made Ag/Ag+ pseudo-reference electrode was used as a reference. The pseudo-reference electrode consisted of a silver wire in a body-glass (PINE research, USA) filled with a solution of 0.01 M silver nitrate (AgNO3, BASi, USA) in tetrabutylammonium tetrafluoroborate (TBABF4, Sigma Aldrich, USA) 0.1 M in dimethyl sulfoxide (DMSO, Sigma Aldrich, USA). The supporting electrolyte consisted of TBABF4 0.1 M dissolved in DMSO. As received TBABF4 and DMSO were used without further purification or drying processes. Furthermore, the testing solutions were prepared by adding compounds 3a–e or 4a–e to the supporting electrolyte for a final concentration of 5 × 10−3 M. Then, cyclic voltammetry (CV) was carried out in a range from −2.0 to 0.75 V vs. Ag/Ag+ at a scan rate of 100 mV s−1 in the cathodic direction to identify any electron transfer reaction. The redox reaction processes associated to compounds 3a–e or 4a–e were further studied by CV at a scan rate of 10, 25, 50, 100, 200, and 300 mV·s−1.

4.9. Cell Lines

The HPV-16 positive cervical tumor line SiHa and the breast tumor cell line MCF-7 were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) (Invitrogen Corporation, Carlsbad CA, United States) enriched with 5% fetal bovine serum (FBS). Medium change and passage were performed every 3 and 4 days, respectively. The SiHa cell line was kindly provided by Ph.D. Gariglio’s Lab from CINVESTAV-IPN. The MCF-7 cell line was kindly provided by Ph.D. Victor Treviño from Tecnológico de Monterrey.

4.10. Cell Proliferation Analysis

Cell proliferation was quantified by violet crystal dye in 1× phosphate-buffered saline (PBS) (2.7 mM KCl, 1.8 mM KH2PO4, 136 mM NaCl, 10 mM Na2HPO4 pH 7.4). The treated cells were incubated in methanol for 15 min and washed two times with water. Cells were dyed with 0.1% crystal violet and washed three times with water, and finally, violet crystal was recovered with 10% acid acetic to be analyzed in microplate reader Multiskan GO Spectrophotometer (Thermo Scientific™, Ratastic, Finland).

5. Conclusions

As we previously mentioned, the synthesis of naphthoquinone–amino acid derivatives has been reported; nonetheless, neither microwave- or ultrasonic-assisted synthesis has been reported. The obtained results on the analysis of the synthetic methodology showed a direct dependence of the stoichiometry of the reactants and the pH, due to the need of the amino acids for their deprotonation, and the yield was increased with the microwave system. On the other hand, some products were obtained directly by precipitation, only with the acidification of reaction mixture after a few hours of rest without further purification. Since naphthoquinones possess redox properties, cyclic voltammetry studies were done, concluding that the redox reaction is a diffusion-controlled quasi-reversible process. The biological evaluation showed a potent proliferation inhibition in cervical and breast cancer cells lines. Remarkably, naphthoquinone–amino acid derivatives, as well as dichloride compounds, showed selectively antitumorigenic properties in cervix and breast cancer cell lines, respectively, positioning them as promising compounds for specific cancer treatment.

Supplementary Materials

The following are available online: NMR and IR spectra of the characterization compounds.

Author Contributions

E.R.-Á. performed the synthesis experiment and characterization of the derivatives. D.d.L. and L.L. designed the synthesis experiment, analyzed the data, and wrote the paper. J.G.A.-H. performed the anticancer experiment, and J.A.L. designed the cancer experiment, analyzed the data, and wrote the paper of the anticancer effect. I.L.E.-G., M.A.M.-S., and H.H. performed the electrochemical experiments, and analyzed and described this section. All authors read and approved the manuscript.

Funding

This research was funded by the National Council for Science and Technology, Grant number CB-2013-01-220844 and PhD Scholarship number 304251.

Acknowledgments

E.R.-Á., D.d.L. and L.L. acknowledge to the group of Instituto de Química of the UNAM, especially to Braulio Rodríguez Molina, to the technical support (Ma. de los Ángeles Peña González, Elizabeth Huerta Salazar, María del Carmen García González and Everardo Tapia Mendoza.), and to all the facilities to perform the characterization of the compounds and material used for the experiments.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. López, L.I.; Vaquera, J.J.; Nery, S.D.; Silva, S.Y. Naphthoquinones; biological properties and synthesis of lawsone and derivatives—A structured review. Vitae 2014, 21, 248–258. [Google Scholar]
  2. Leyva, E.; Loredo-Carrillo, S.E.; López, L.I.; Escobedo-Avellaneda, E.G.; Navarro-Tovar, G. Importancia química y biológica de naftoquinonas. Revisión bibliográfica. Afinidad 2017, 74, 36–50. [Google Scholar]
  3. Li, C.J.; Li, Y.Z.; Pinto, A.V.; Pardee, A.B. Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: Combining drugs imposes different artificial checkpoints. Proc. Natl. Acad. Sci. USA 1999, 96, 13369–13374. [Google Scholar] [CrossRef] [PubMed]
  4. Chen, J.; Huang, Y.W.; Liu, G.; Afrasiabi, Z.; Sinn, E.; Padhye, S.; Ma, Y. The cytotoxicity and mechanisms of 1,2-naphthoquinone thiosemicarbazone and its metal derivatives against MCF-7 human breast cancer cells. Toxicol. Appl. Pharmacol. 2004, 197, 40–48. [Google Scholar] [CrossRef]
  5. Kongkathip, N.; Kongkathip, B.; Siripong, P.; Sangma, C.; Luangkamin, S.; Niyomdecha, M.; Pattanapa, S.; Piyaviriyagul, S.; Kongsaeree, P. Potent antitumor activity of synthetic 1,2-naphthoquinones and 1,4-naphthoquinones. Bioorg. Med. Chem. 2003, 11, 3179–3191. [Google Scholar] [CrossRef]
  6. Kongkathip, N.; Luangkamin, S.; Kongkathip, B.; Sangma, C.; Grigg, R.; Kongsaeree, P.; Prabpai, S.; Pradidphol, N.; Piyaviriyagul, S.; Siripong, P. Synthesis of novel rhinacanthins and related anticancer naphthoquinone esters. J. Med. Chem. 2004, 47, 4427–4438. [Google Scholar] [CrossRef]
  7. Pedersen, J.A. On the application of electron paramagnetic resonance in the study of naturally occurring quinones and quinols. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2002, 58, 1257–1270. [Google Scholar] [CrossRef]
  8. Coates, C.S.; Ziegler, J.; Manz, K.; Good, J.; Kang, B.; Milikisiyants, S.; Chatterjee, R.; Hao, S.; Golbeck, J.H.; Lakshmi, K.V. The structure and function of quinones in biological solar energy transduction: A cyclic voltammetry, EPR, and hyperfine sub-level correlation (HYSCORE) spectroscopy study of model naphthoquinones. J. Phys. Chem. B 2013, 117, 7210–7220. [Google Scholar] [CrossRef]
  9. Maldonado, T.; Martínez-González, E.; Frontana, C. Intramolecular hydrogen bonding/selfprotonation processes modulated by the substituent effect in hydroxyl-substituted naphthoquinones. Electroanalysis 2016, 28, 2827–2833. [Google Scholar] [CrossRef]
  10. Smithson, C.S.; MacDonald, D.J.; Letvenuk, T.M.; Carello, C.E.; Jennings, M.; Lough, A.J.; Britten, J.; Decken, A.; Preuss, K.E. A 1,2,3-dithiazolyl-o-naphthoquinone: A neutral radical with isolable cation and anion oxidation states. Dalton Trans. 2016, 45, 9608–9620. [Google Scholar] [CrossRef]
  11. Tarábek, J.; Wen, J.; Dron, P.I.; Pospísil, L.; Michl, J. EPR Spectroscopy of radical ion of a 2,3-diamino-1,4-naphthoquinone derivative. J. Org. Chem. 2018, 83, 5474–5479. [Google Scholar] [CrossRef]
  12. Mondal, S.; Bera, S.; Ghosh, P. Redox cascades and making of a C-C bond: 1,2-benzodiazinyl radicals and a copper complex of a benzodiazine. J. Org. Chem. 2019, 84, 1871–1881. [Google Scholar] [CrossRef]
  13. Wardman, P. Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia. Curr. Med. Chem. 2001, 8, 739–761. [Google Scholar] [CrossRef]
  14. Ham, S.W.; Choe, J.I.; Wang, M.F.; Peyregne, V.; Carr, B.I. Fluorinated quinoid inhibitor: Possible “pure” arylator predicted by the simple theoretical calculation. Bioorg. Med. Chem. Lett. 2004, 14, 4103–4105. [Google Scholar] [CrossRef]
  15. Kar, S.; Wang, M.; Ham, S.W.; Carr, B.I. Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK. Biochem. Pharmacol. 2006, 72, 1217–1227. [Google Scholar] [CrossRef]
  16. Park, H.; Carr, B.I.; Li, M.; Ham, S.W. Fluorinated NSC as a Cdc25 inhibitor. Bioorg. Med. Chem. Lett. 2007, 17, 2351–2354. [Google Scholar] [CrossRef]
  17. Troshkova, N.M.; Goryunov, L.I.; Shteingarts, V.D.; Zakharova, O.D.; Ovchinnikova, L.P.; Nevinsky, G.A. Synthesis and cytotoxicity evaluation of polyfluorinated 1,4-naphthoquinones containing amino acid substituents. J. Fluorine Chem. 2014, 164, 18–26. [Google Scholar] [CrossRef]
  18. Marastoni, M.; Trapella, C.; Scotti, A.; Fantinati, A.; Ferretti, V.; Marzola, E.; Eleonora, G.; Gavioli, R.; Preti, D. Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors. J. Enzym. Inhib. Med. Ch. 2017, 32, 865–877. [Google Scholar] [CrossRef]
  19. Bittner, S.; Gorohovsky, S.; Paz-Tal, L.O.; Becker, J.Y. Synthesis, electrochemical and spectral properties of some ω-N-quinonyl amino acids. Amino Acids 2002, 22, 71–93. [Google Scholar] [CrossRef]
  20. Tandon, V.K.; Maurya, H.K. ‘On water’: Unprecedented nucleophilic substitution and addition reactions with 1,4-quinones in aqueous suspension. Tetrahedron Lett. 2009, 50, 5896–5902. [Google Scholar] [CrossRef]
  21. Katritzky, A.R.; Huang, L.; Sakhuja, R. Efficient syntheses of naphthoquinone-dipeptides. Synthesis 2010, 12, 2011–2016. [Google Scholar] [CrossRef]
  22. Mital, A.; Sonawane, M.; Bindal, S.; Mahlavat, S.; Negi, V. Substituted 1,4-naphthoquinones as a new class of antimycobacterial agents. Der Pharm. Chem. 2010, 2, 63–73. [Google Scholar]
  23. de Moraes, T.A.; Filha, M.J.; Camara, C.A.; Silva, T.M.; Soares, B.M.; Bomfim, I.S.; Pessoa, C.; Ximenes, G.C.; Silva, V.A., Jr. Synthesis and cytotoxic evaluation of a series of 2-amino-naphthoquinones against human cancer cells. Molecules 2014, 19, 13188–13199. [Google Scholar] [CrossRef]
  24. Figurka, O.; Kochubei, V.; Khomyak, S.; Platonov, M.; Martynyuk, I.; Stadnichuk, O.; Gubriy, Z.; Kurka, M.; Novikov, V. Synthesis and characteristics of amino acid derivatives of 1,4-naphthoquinone. J. Chem. Pharm. Res. 2015, 7, 1289–1294. [Google Scholar]
  25. Janeczko, M.; Demchuk, O.M.; Strzelecka, D.; Kubinski, K.; Maslyk, M. New family of antimicrobial agents derived from 1,4-naphthoquinone. Eur. J. Med. Chem. 2016, 124, 1019–1025. [Google Scholar] [CrossRef]
  26. Fihurka, O.; Kochubei, V.; Khomyak, S.; Novikov, V. Thermal analysis of 2-amino-3-chloro-1,4-naphthoquinones. Int. J. ChemTech Res. 2017, 10, 985–993. [Google Scholar]
  27. Bittner, S.; Gorohovsky, S.; Lozinsky, E.; Shames, A.I. EPR study of anion radical of various N-quinonyl amino acids. Amino Acids 2000, 19, 439–449. [Google Scholar] [CrossRef]
  28. Rahimipour, S.; Weiner, L.; Fridkin, M.; Shresthe-Dawadi, P.B.; Bittner, S. Novel naphthoquinonyl derivatives: Potential structural components for the synthesis of cytotoxic peptides. Lett. Pept. Sci. 1996, 3, 263–274. [Google Scholar] [CrossRef]
  29. Gorohovsky, S.; Bittner, S. Novel N-quinonyl amino acids and their transformation to 3-substituted p-isoxazinones. Amino acids. 2001, 20, 134–144. [Google Scholar] [CrossRef]
  30. López, L.I.; Vaquera, J.J.; Sáenz, A.; Silva, S.Y. Ultrasonic and microwave assisted synthesis of nitrogen-containing derivatives of juglone as potential antibacterial agents. Lett. Org. Chem. 2014, 11, 573–582. [Google Scholar] [CrossRef]
  31. Leyva, E.; López, L.I.; García de la Cruz, R.F.; Espinosa-González, C.G. Synthesis and studies of the antifungal activity of 2-anilino-/2,3-dianilino-/2-phenoxy- and 2,3-diphenoxy-1,4-naphthoquinones. Res. Chem. Intermed. 2017, 43, 1813–1827. [Google Scholar] [CrossRef]
  32. López, L.I.; Nery, S.D.; Sáenz, A.; de Loera, D. Facile synthesis of aminonaphthoquinone Mannich bases by noncatalytic multicomponent reaction. Synth. Commun. 2017, 47, 2247–2253. [Google Scholar] [CrossRef]
  33. Ge, Y.; Li, A.; Wu, J.; Feng, H.; Wang, L.; Liu, H.; Xu, Y.; Xu, Q.; Zhao, L.; Li, Y. Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors. Eur. J. Med. Chem. 2017, 128, 180–191. [Google Scholar] [CrossRef]
  34. Ruda, N.V.; Drachuk, O.P.; Stepanuyk, G.I. The acute toxicity study of new amino acid-containing derivatives of 1,4-naphthoquinone. Available online: http://nuph.edu.ua/wp-content/uploads/2015/04/Microsoft-Word-UBFG_3_2013_31.doc.pdf (accessed on 19 November 2019).
  35. Guin, P.S.; Das, S.; Mandal, P.C. Electrochemical reduction of quinones in different media: A review. Int. J. Electrochem. 2011, 2011, 1–22. [Google Scholar] [CrossRef]
  36. Song, Y.; Buettner, G.R. Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide. Free Radic. Biol. Med. 2010, 49, 919–962. [Google Scholar] [CrossRef]
  37. Heinze, J. Cyclic voltammetry—“Electrochemical spectroscopy”. New analytical methods (25). Angew. Chem. Int. Edit. 1984, 23, 831–847. [Google Scholar] [CrossRef]
  38. Bard, A.J.; Faulkner, L.R. Electrochemical Methods: Fundamentals and Applications, 2nd ed.; John Wiley & Sons Inc.: New York, NY, USA, 2000. [Google Scholar]
  39. da Cruz, E.H.; Hussene, C.M.; Dias, G.G.; Diogo, E.B.; de Melo, I.M.; Rodrigues, B.L.; da Silva, M.G.; Valenca, W.O.; Camara, C.A.; de Oliveira, R.N.; et al. 1,2,3-Triazole-, arylamino- and thio-substituted 1,4-naphthoquinones: Potent antitumor activity, electrochemical aspects, and bioisosteric replacement of C-ring-modified lapachones. Bioorg. Med. Chem. 2014, 22, 1608–1619. [Google Scholar] [CrossRef] [Green Version]
  40. Francisco, A.I.; Casellato, A.; Neves, A.P.; Carneiro, J.W.; Vargas, M.D.; Visentin, L.do.C.; Magalhaes, A.; Camara, C.A.; Pessoa, C.; Costa-Lotufo, L.V.; et al. Novel 2-(R-phenyl)amino-3-(2-methylpropenyl)-[1,4]-naphthoquinones: Synthesis, characterization, electrochemical behavior and antitumor activity. J. Braz. Chem. Soc. 2010, 21, 169–178. [Google Scholar] [CrossRef]
  41. Leyva, E.; López, L.I.; Loredo-Carrillo, S.E.; Rodríguez-Kessler, M.; Montes-Rojas, A. Synthesis, spectral and electrochemical characterization of novel 2-(fluoroanilino)-1,4-naphthoquinones. J. Fluor. Chem. 2011, 132, 94–101. [Google Scholar] [CrossRef]
  42. Diogo, E.B.; Dias, G.G.; Rodrigues, B.L.; Guimarães, T.T.; Valença, W.O.; Camara, C.A.; de Oliveira, R.N.; da Silva, M.G.; Ferreira, V.F.; de Paiva, Y.G.; et al. Synthesis and anti-trypanosoma cruzi activity of naphthoquinone-containing triazoles: Electrochemical studies on the effects of the quinoidal moiety. Bioorg. Med. Chem. 2013, 21, 6337–6348. [Google Scholar] [CrossRef] [Green Version]
  43. Emadi, A.; Le, A.; Harwood, C.J.; Stagliano, K.W.; Kamangar, F.; Ross, A.E.; Cooper, C.R.; Dang, C.V.; Karp, J.E.; Vulca-Ross, M. Metabolic and electrochemical mechanisms of dimeric naphthoquinones cytotoxicity in breast cancer cells. Bioorg. Med. Chem. 2011, 19, 7057–7062. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Gómez, M.; González, F.J.; González, I. Effect of host and guest structures on hydrogen bonding association: Influence on stoichiometry and equilibrium constants. J. Electrochem. Soc. 2003, 150, 527–534. [Google Scholar] [CrossRef]
  45. Gupta, N.; Linschitz, H. Hydrogen-bonding and protonation effects in electrochemistry of quinones in aprotic solvents. J. Am. Chem. Soc. 1997, 119, 6384–6391. [Google Scholar] [CrossRef]
  46. Shi, R.R.; Tessensohn, M.E.; Lauw, S.J.; Foo, N.A.; Webster, R.D. Tuning the reduction potential of quinones by controlling the effects of hydrogen bonding, protonation and proton-coupled electron transfer reactions. Chem. Commun. 2019, 55, 2277–2280. [Google Scholar] [CrossRef] [PubMed]
  47. Gómez, M.; González, F.J.; González, I. A Model for characterization of successive hydrogen bonding interactions with electrochemically generated charged species. The quinone electroreduction in the presence of donor protons. Electroanalysis 2003, 15, 635–645. [Google Scholar] [CrossRef]
  48. Goulart, M.O.; Zani, C.L.; Tonholo, J.; Freitas, L.R.; de Abreu, F.C.; Oliveira, A.B.; Raslan, D.D.; Starling, S.; Chiari, E. Trypanocidal activity and redox potential of heterocyclic- and 2-hydroxy-naphthoquinones. Bioorg. Med. Chem. Lett. 1997, 7, 2043–2048. [Google Scholar] [CrossRef]
  49. Ashnagar, A.; Bruce, J.M.; Dutton, P.L.; Prince, R.C. One- and two-electron reduction of hydroxy-1,4-naphthoquinones and hydroxy-9,10-anthraquinones: The role of internal hydrogen bonding and its bearing on the redox chemistry of the anthracycline antitumour quinones. Biochim. Biophys. Acta 1984, 801, 351–359. [Google Scholar] [CrossRef]
  50. Aguilar-Martínez, M.; Cuevas, G.; Jiménez-Estrada, M.; González, I.; Lotina-Hennsen, B.; Macías-Ruvalcaba, N. An experimental and theoretical study of the substituent effects on the redox properties of 2-[(R-phenyl)amine]-1,4-naphthalenediones in acetonitrile. J. Org. Chem. 1999, 64, 3684–3694. [Google Scholar] [CrossRef]
  51. Hillard, E.A.; de Abreu, F.C.; Ferreira, D.C.; Jaouen, G.; Goulart, M.O.; Amatore, C. Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds. Chem. Commun. 2008, 23, 2612–2628. [Google Scholar] [CrossRef]
Sample Availability: Samples of the compounds 3a–e and 4a–e are available from the authors.
Molecules 24 04285 g001 550
Figure 1. Preparation of 3a–e and 4a–e derivatives.
Figure 1. Preparation of 3a–e and 4a–e derivatives.
Molecules 24 04285 g001
Molecules 24 04285 g002 550
Figure 2. Cyclic Voltammetry curves of 5 mM naphthoquinone–amino acid derivatives (A) 3a–e and (B) 4a–e in TBABF4 0.1 M/DMSO at 100 mV s−1 on a glassy carbon disk working electrode at room temperature.
Figure 2. Cyclic Voltammetry curves of 5 mM naphthoquinone–amino acid derivatives (A) 3a–e and (B) 4a–e in TBABF4 0.1 M/DMSO at 100 mV s−1 on a glassy carbon disk working electrode at room temperature.
Molecules 24 04285 g002
Molecules 24 04285 g003 550
Figure 3. Proliferation effect of naphthoquinone–amino acid derivatives was evaluated in cancer cell lines derived from cervix and breast. (A) SiHa cervical cancer cells were treated with 0.1 mM of naphthoquinone–amino acid derivatives to assay proliferation rate at 72 h post-treatment. (B) MCF-7 breast cancer cells were treated with 0.1 mM of naphthoquinone–amino acid derivatives to assay proliferation rate at 72 h post-treatment. Cells treated with 0.001% of DMSO were used as control.
Figure 3. Proliferation effect of naphthoquinone–amino acid derivatives was evaluated in cancer cell lines derived from cervix and breast. (A) SiHa cervical cancer cells were treated with 0.1 mM of naphthoquinone–amino acid derivatives to assay proliferation rate at 72 h post-treatment. (B) MCF-7 breast cancer cells were treated with 0.1 mM of naphthoquinone–amino acid derivatives to assay proliferation rate at 72 h post-treatment. Cells treated with 0.001% of DMSO were used as control.
Molecules 24 04285 g003
Table
Table 1. Effect of reaction conditions of 3a–c derivatives in their yields.
Table 1. Effect of reaction conditions of 3a–c derivatives in their yields.
Method Compound Yield (%)
Base3a3b3c
RTSNoneNrNrNr
TEATpTpTp
K2CO3TpTpTp
RSNoneTpTpTp
TEA325030
K2CO3235020
MASNone303028
TEA747371
K2CO3656462
AcONa595652
KOH747372
RTS: Room temperature synthesis (25 °C for 24–48 h); RS: Reflux synthesis (90 °C for 24 h); MAS: Microwave-assisted synthesis (110 °C, 250 W, 25 min); Nr: No reaction; Tp: Trace product.
Table
Table 2. Synthesis of 3a–e and 4a–e derivatives by MAS and UAS.
Table 2. Synthesis of 3a–e and 4a–e derivatives by MAS and UAS.
CompoundNq–aaMAS a (%)UAS b (%)
TEAKOHTEAKOH
3a1:2.080866878
3b1:1.285917581
3c1:1.582877165
3d1:1.581856778
3e1:1.579807782
4a1:2.091868680
4b1:1.295878570
4c1:1.578898068
4d1:1.591827585
4e1:1.578857585
a MAS: 110 °C, 250 W, 25 min. b UAS: 25–40 °C, 1 h. Optimized conditions: Dioxane/water (4:1), TEA (1 mmol)/KOH (3N) 5 mL. Nq–aa: Naphthoquinone–amino acid proportion.
Table
Table 3. Electrochemical parameters of naphthoquinone derivatives with amino acid substituents a.
Table 3. Electrochemical parameters of naphthoquinone derivatives with amino acid substituents a.
CompoundEpaEpcΔEp bE1/2 cipaipc|ipa/ipc|
(V)(V)(V)(V)(mA cm−2)
3a-------
3b−1.18−1.300.12−1.240.28−0.290.95
3c−1.15−1.300.15−1.230.16−0.170.93
3d−1.17−1.310.13−1.240.28−0.290.94
3e−1.16−1.320.16−1.240.05−0.060.91
4a−1.04−1.180.14−1.110.36−0.380.97
4b−1.07−1.190.12−1.130.37−0.410.90
4c−1.04−1.160.12−1.100.27−0.310.89
4d−1.07−1.200.13−1.130.28−0.261.06
4e−1.05−1.150.11−1.100.26−0.260.98
a Determined by cyclic voltammetry in TBABF4 0.1 M/DMSO at 100 mV/s. The potentials are given with respect to the Ag/Ag+ pseudo-reference electrode; b ΔEp = Epc − Epa; c E1/2 = (Epa + Epc)/2.

Share and Cite

MDPI and ACS Style

Rivera-Ávalos, E.; de Loera, D.; Araujo-Huitrado, J.G.; Escalante-García, I.L.; Muñoz-Sánchez, M.A.; Hernández, H.; López, J.A.; López, L. Synthesis of Amino Acid–Naphthoquinones and In Vitro Studies on Cervical and Breast Cell Lines. Molecules 2019, 24, 4285. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules24234285

AMA Style

Rivera-Ávalos E, de Loera D, Araujo-Huitrado JG, Escalante-García IL, Muñoz-Sánchez MA, Hernández H, López JA, López L. Synthesis of Amino Acid–Naphthoquinones and In Vitro Studies on Cervical and Breast Cell Lines. Molecules. 2019; 24(23):4285. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules24234285

Chicago/Turabian Style

Rivera-Ávalos, Ernesto, Denisse de Loera, Jorge Gustavo Araujo-Huitrado, Ismailia Leilani Escalante-García, Miguel Antonio Muñoz-Sánchez, Hiram Hernández, Jesús Adrián López, and Lluvia López. 2019. "Synthesis of Amino Acid–Naphthoquinones and In Vitro Studies on Cervical and Breast Cell Lines" Molecules 24, no. 23: 4285. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules24234285

Article Metrics

Back to TopTop